In addition, we examined the RET fusion positive to the RET fusion negative papillary thyroid carcinoma (PTC) cohorts and found that the age of the RET fusion positive PTC cohort was significantly younger then the RET fusion negative PTC cohort (33 vs 62 years old <0.001) (Supplementary Table 3). The gene discussed is RET; the disease is differentiated thyroid carcinoma.